PledPharma develops and commercializes drugs for the treatment of life-threatening diseases caused by chemotherapy and paracetamol poisoning... Read more
PledPharma develops and commercializes drugs for the treatment of life-threatening diseases caused by chemotherapy and paracetamol poisoning... Read more
CEO
Nicklas Westerholm
News
Apr 26, 2021
MarketScreener
PledPharma AB: Egetis Therapeutics : Corporate presentation, slides
Nov 10, 2020
MarketScreener
PledPharma AB: PledPharma : NOTICE TO ATTEND EXTRAORDINARY GENERAL MEETING IN PLEDPHARMA AB
Nov 05, 2020
MarketScreener
PledPharma AB: PledPharma : publishes prospectus and updated financial information in connection with fully guaranteed rights issue and the admission to trading of shares
Jan 31, 2019
FinanzNachrichten
PledPharma: PledPharma AB: Aladote's data has been selected for presentation at The International Liver Congress
Jan 17, 2019
streetinsider
Press Release: PledPharma : PledPharma presents PledOx®'s phase III program at the Gastrointestinal (GI) Cancers Symposium
Jan 10, 2019
FE Investegate
PledPharma: PledPharma AB : First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma
Jan 10, 2019
CENTRALCHARTS
Press Release: PledPharma : First Asian patient has been included in the global Phase III program for PledOx® and will trigger a milestone payment of 600 MJPY (c.49 MSEK) to PledPharma
Jan 07, 2019
Korea Newswire
Press Release: PledPharma : Solasia Initiates Phase III Program for PledOx® in Japan
Dec 24, 2018
BioPortfolio
PledPharma: PledPharma AB PledPharma applies for an Orphan Drug Designation ODD in the US for Aladote
Dec 13, 2018
BioPortfolio
PledPharma: PledPharma AB PledPharma presents results from study on drug candidate Aladote for paracetamol poisoning at a global toxicology conference